(Q33222118)

24 July 2017

1 reference

title

Screening for primary open-angle glaucoma in the developed world: are we there yet? (English)

1 reference

Demosthenes Papamatheakis

24 July 2017

1 reference

object named as

Demosthenes Papamatheakis

series ordinal

3

0 references

author name string

Paul Harasymowycz

series ordinal

1

1 reference

24 July 2017

Alvine Kamdeu Fansi

series ordinal

2

1 reference

24 July 2017

publication date

1 August 2005

1 reference

Canadian Journal of Ophthalmology

24 July 2017

published in

1 reference

24 July 2017

volume

40

1 reference

24 July 2017

issue

4

1 reference

24 July 2017

page(s)

477-486

1 reference

The projected increase in glaucoma due to an ageing population

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Longitudinal prevalence of major eye diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Early Manifest Glaucoma Trial: design and baseline data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

The age distribution of primary open angle glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Prevalence and causes of visual field loss in the elderly and associations with impairment in daily functioning: the Rotterdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Adult-onset primary open-angle glaucoma caused by mutations in optineurin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Intra-eye pressure range and pulse profiles in normals with the Pulsair non-contact tonometer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Screening for glaucoma in a Brisbane general practice--the role of tonometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Accuracy of Goldmann tonometry after refractive surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Chronic human glaucoma causing selectively greater loss of large optic nerve fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Screening for glaucoma with frequency-doubling technology and Damato campimetry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Accuracy of glaucoma detection with frequency-doubling perimetry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Frequency doubling perimetry in glaucoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Laterality of the performance of glaucoma mass screening using frequency-doubling technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Clinical classification of glaucomatous visual field loss by frequency doubling perimetry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Standard achromatic perimetry, short wavelength automated perimetry, and frequency doubling technology for detection of glaucoma damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Blue-on-yellow perimetry using an Armaly glaucoma screening program.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Can the current oculokinetic perimetry chart be improved?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Evaluation of oculokinetic perimetry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Clinician change detection viewing longitudinal stereophotographs compared to confocal scanning laser tomography in the LSU Experimental Glaucoma (LEG) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: comparison of scanning laser tomography with conventional perimetry and optic disc photography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Identification of early glaucoma cases with the scanning laser ophthalmoscope.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Detection of optic disc change with the Heidelberg retina tomograph before confirmed visual field change in ocular hypertensives converting to early glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Using optical imaging summary data to detect glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

The retinal nerve fiber layer thickness in ocular hypertensive, normal, and glaucomatous eyes with optical coherence tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Optical coherence tomography: a new tool for glaucoma diagnosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Optical coherence tomography: an introduction to the technique and its use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Evaluation of retinal nerve fiber layer thickness in the area of apparently normal hemifield in glaucomatous eyes with optical coherence tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Fourier analysis of optical coherence tomography and scanning laser polarimetry retinal nerve fiber layer measurements in the diagnosis of glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

The sensitivity and specificity of scanning laser polarimetry in the detection of glaucoma in a clinical setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Detection of glaucoma with scanning laser polarimetry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Diagnostic accuracy of the GDx VCC for glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Screening for Glaucoma in a Medical Clinic With Photographs of the Nerve Fiber Layer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Telemedicine screening of glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Tele-ophthalmic screening using digital imaging devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Glaucoma screening: the importance of combining test data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Screening models for glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Correlation of visual field with quality-of-life measures at diagnosis in the Collaborative Initial Glaucoma Treatment Study (CIGTS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Quality of life in newly diagnosed glaucoma patients : The Collaborative Initial Glaucoma Treatment Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Influence of glaucomatous visual field loss on health-related quality of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Selective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Design of low cost glaucoma screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

The cost-effectiveness of various modes of screening for primary open angle glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Brisbane GPs' perceptions of screening for primary open-angle glaucoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

Do locally agreed guidelines for optometrists concerning the referral of glaucoma suspects influence referral practice?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

The role of frequency doubling technology (FDT) in glaucoma screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Patient persistency with pharmacotherapy in the management of glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980010-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0008-4182(05)80010-9

1 reference

24 July 2017

1 reference